Related by context. All words. (Click for frequent words.) 73 investigational oral 72 investigational drug 71 mTOR inhibitor 70 BAY #-# 70 investigational humanized monoclonal antibody 70 Mipomersen 69 orally bioavailable 69 PDE4 inhibitor 69 Dapagliflozin 68 Phase 2b clinical 68 oral prodrug 68 JAK inhibitor 68 oral formulation 67 Laquinimod 67 LY# [002] 67 Phenoptin 67 Phase 2a clinical 67 histone deacetylase HDAC inhibitor 67 axitinib 67 polymerase inhibitor 67 MAGE A3 ASCI 67 INCB# [001] 67 investigational 67 Phase IIa trial 67 Phase IIa clinical 67 orally administered 66 Perifosine 66 selective modulator 66 ELND# 66 Panzem R 66 elotuzumab 66 vascular disrupting agent 66 Zolinza 66 Phase 1b trial 66 Phase III clinical 66 NOXAFIL 66 anticancer compound 66 injectable formulation 66 angiogenesis inhibitor 66 sodium glucose cotransporter 66 integrase inhibitor 66 Serdaxin 66 multi kinase inhibitor 66 Phase 2b study 66 phase IIb clinical 66 anticancer agent 66 FOLOTYN ® 66 HCV protease inhibitor 65 Phase Ib study 65 Nexavar ® 65 sorafenib tablets 65 atypical antipsychotic 65 non nucleoside inhibitor 65 liposomal formulation 65 LY# [003] 65 investigational compounds 65 albinterferon alfa 2b 65 IAP inhibitors 65 Phase IIb trials 65 HGS# 65 Phase 2a trial 65 PNP inhibitor 65 Ambrisentan 65 PSN# [002] 65 mertansine 65 SCH # 65 KRN# 65 humanized monoclonal antibody 65 MAP# 65 forodesine 65 Abiraterone acetate 65 Phase 1b clinical 65 Phase IIb clinical 65 phase IIb trial 65 diabetic neuropathic pain 65 Ceflatonin 65 receptor antagonist 65 Plicera 65 tanespimycin 65 registrational trial 65 PKC# 65 Phase 2b trial 65 JANUVIA 64 Traficet EN 64 intranasal formulation 64 Phase Ib 64 Marqibo 64 Phase Ib clinical 64 HuMax CD4 64 docetaxel Taxotere R 64 Ixempra 64 virus HCV protease inhibitor 64 GW# [003] 64 relapsing remitting multiple sclerosis 64 IMiD 64 sorafenib Nexavar 64 perifosine 64 TELINTRA 64 long acting muscarinic 64 teduglutide 64 IMGN# 64 PEG Interferon lambda 64 Archexin 64 pivotal Phase III 64 carfilzomib 64 Amrubicin 64 pomalidomide 64 YONDELIS 64 Phase IIb trial 64 Tarceva TM 64 PEGylated Fab fragment 64 MEK inhibitor 64 Azedra 64 vandetanib 64 Belimumab 64 biologic therapy 64 alvespimycin 64 phase IIb 64 Tasigna nilotinib 64 receptor tyrosine kinase inhibitor 64 registrational 64 HIV integrase inhibitor 64 Pimavanserin 64 BMS # 64 Tyrima 64 kinase inhibitor 64 AEGR 64 Tanespimycin 64 Elesclomol 64 vidofludimus 64 torezolid phosphate 64 JAK2 inhibitor 64 investigational pan BCR 64 small molecule Hedgehog 64 prodrug 64 prasugrel CS 64 proteasome inhibitor 64 Ofatumumab 64 HuMax EGFr 64 roflumilast 64 disease modifying 64 rilonacept 64 Vilazodone 63 TYKERB 63 Afatinib 63 PXD# 63 NVA# 63 cathepsin K inhibitor 63 receptor agonist 63 Pirfenidone 63 Tofacitinib 63 neratinib 63 novel histone deacetylase 63 daclizumab 63 lapatinib Tykerb 63 Phase 2a 63 Alzhemed TM 63 INC# 63 desvenlafaxine 63 humanized anti 63 RG# [001] 63 Carfilzomib 63 Pazopanib 63 evaluating tivozanib 63 eltrombopag 63 PS# [001] 63 fostamatinib 63 selective inhibitor 63 MORAb 63 AZILECT ® 63 angiotensin receptor blocker ARB 63 ISIS # 63 Ocrelizumab 63 antagonist LAMA 63 PREOS 63 peripherally acting 63 RDEA# 63 relapsed refractory multiple myeloma 63 investigational protease inhibitor 63 pseudobulbar affect PBA 63 modulator SERM 63 sunitinib malate 63 regorafenib 63 Omacetaxine 63 TACI Ig 63 Tezampanel 63 reslizumab 63 pan HDAC inhibitor 63 Icatibant 63 AZD# 63 pertuzumab 63 panitumumab Vectibix 63 lomitapide 63 NGX# 63 diarrhea predominant irritable 63 AZILECT R 63 phase IIa clinical 63 edoxaban 63 enzastaurin 63 ATL/TV# 63 PF # [001] 63 thymalfasin 63 deforolimus 63 AEZS 63 novel prodrug 63 talactoferrin 63 TREANDA 63 HER2 positive metastatic breast 63 Safinamide 63 Dasatinib 63 adalimumab Humira 63 inhaled corticosteroid ICS 63 cilengitide 63 HDAC inhibitor 63 tasocitinib 63 romidepsin 63 FTY# fingolimod 63 oral anticoagulant 63 PRTX 62 orally administered inhibitor 62 Milnacipran 62 Vaprisol 62 Muraglitazar 62 ADP receptor antagonist 62 NKTR 62 oral ridaforolimus 62 angiotensin II receptor blocker 62 CCR5 antagonist 62 Cimzia R 62 Phase 2b clinical trials 62 PRX # 62 dipeptidyl peptidase 4 62 ocrelizumab 62 IMiDs R 62 fluoroquinolone antibiotic 62 tyrosine kinase inhibitor 62 bazedoxifene 62 Aurexis 62 seliciclib CYC# 62 Eltrombopag 62 highly selective inhibitor 62 visilizumab 62 Aurora kinase inhibitor 62 CRx 62 Boceprevir 62 Rebif ® 62 Silodosin 62 Methylnaltrexone 62 Darusentan 62 Denufosol 62 Maribavir 62 subcutaneously administered 62 lumiliximab 62 methylnaltrexone bromide 62 serotonin norepinephrine reuptake inhibitor 62 IMiDs ® 62 AEG# 62 rNAPc2 62 RoACTEMRA 62 Vandetanib 62 otelixizumab 62 Hsp# inhibitor 62 Raptiva R 62 Lodotra 62 Fodosine 62 Xanafide 62 lorvotuzumab mertansine 62 Alpharadin 62 Aflibercept 62 liprotamase 62 Clolar 62 Cimzia ® 62 AVASTIN 62 Romidepsin 62 Maraviroc 62 Ceflatonin R 62 Cloretazine 62 ISENTRESS 62 acting muscarinic antagonist 62 teplizumab 62 muraglitazar 62 tiapamil 62 transcriptase inhibitor NNRTI 62 LibiGel ® 62 PD LID 62 EOquin 62 Menerba 62 LAF# 62 IL# PE#QQR 62 Torisel 62 Phase IIa 62 bortezomib Velcade 62 HuLuc# 62 immunomodulator 62 cell lymphoma CTCL 62 MGCD# [001] 62 AP# [003] 62 methylnaltrexone 62 ganetespib 62 Troxatyl 62 inhaled formulation 62 Linaclotide 62 TORISEL 62 Bezielle 62 PEG SN# 62 incyclinide 62 TNF Tumor Necrosis Factor 62 SNRI 62 BCX# 62 T DM1 62 SARMs 62 Zalbin 62 SUTENT 62 Enzastaurin 62 severe gastroparesis 62 TRX1 62 antisense drug 62 tezampanel 62 Syncria 62 Cimzia TM 62 novel oral anticoagulant 62 Clevudine 62 selective agonist 62 TBC# 62 Apixaban 62 MEK inhibitors 62 rasagiline tablets 62 baminercept 62 tocilizumab 62 generation purine nucleoside 62 EOquin TM 62 Fablyn 61 DPP4 inhibitor 61 nucleoside analog 61 Pradefovir 61 ceftaroline 61 relapsed multiple myeloma 61 Elvitegravir 61 direct thrombin inhibitor 61 etravirine 61 phase IIb study 61 Phase III clinical trials 61 GSK '# 61 mGluR5 negative 61 IMA# 61 alogliptin 61 Tasimelteon 61 Epratuzumab 61 Phase Ib clinical trials 61 registrational studies 61 mGluR2 positive 61 Atrasentan 61 entinostat 61 eniluracil 61 ZOLINZA 61 PROVENGE sipuleucel T 61 Nanobody 61 LIALDA 61 selective kinase inhibitor 61 linaclotide 61 Debio 61 Onbrez Breezhaler 61 Afinitor ® 61 ATL# [001] 61 Bicifadine 61 Velcade bortezomib 61 MLN# 61 somatostatin analogue 61 orphan medicinal product 61 Sym# 61 Voreloxin 61 renin inhibitor 61 desvenlafaxine succinate 61 Amigal 61 Vidaza azacitidine 61 QNEXA 61 subcutaneous formulation 61 rFVIIIFc 61 SAR# [004] 61 post herpetic neuralgia PHN 61 BENLYSTA ® 61 DB# [003] 61 R#/MEM # 61 Prodarsan ® 61 Roflumilast 61 chemotherapeutic agent 61 tablet formulation 61 NP2 Enkephalin 61 bosutinib 61 depsipeptide 61 LymphoStat B belimumab 61 monotherapy 61 bendamustine 61 Phase 2b 61 Prestara 61 ofatumumab 61 Satraplatin 61 refractory gout 61 fenofibric acid 61 Guanilib 61 xanthine oxidase inhibitor 61 adipiplon 61 ZD# [001] 61 Diamyd ® 61 SRT# [003] 61 temsirolimus 61 zileuton 61 immunomodulatory 61 Iloperidone 61 QLT# 61 Aliskiren 61 satraplatin 61 Ozarelix 61 Irinotecan 61 Zerenex 61 Phase IIb clinical trials 61 CYC# 61 ALN PCS 61 Romiplostim 61 Tolvaptan 61 Ixabepilone 61 6R BH4 61 huC# DM4 61 selective estrogen receptor 61 dalbavancin 61 CA4P 61 SERMs 61 CIMZIA TM 61 vemurafenib 61 Genasense ® 61 ATHX 61 immunotherapeutic agent 61 preclinical studies 61 laquinimod 61 Phase IIb 61 tipifarnib 61 TG# [003] 61 cutaneous T cell 61 zanolimumab 61 Elagolix 61 relapsing multiple sclerosis 61 mitogen activated ERK kinase 61 laropiprant 61 insulin sensitizer 61 obatoclax 61 oral anticancer 61 selective androgen receptor modulator 61 Tesetaxel 61 tolerability 61 INCB# [002] 61 Phase 1a clinical 61 dasatinib Sprycel ® 61 mild vasodilator 61 thalidomide Thalomid 61 lasofoxifene 61 Triolex 61 MAA submission 61 orally dosed 61 efficacy tolerability 61 phase IIa 61 investigational monoclonal antibody 61 targeting CD# 61 alvimopan 61 imatinib Gleevec ® 61 orphan designation 61 elvitegravir 61 #D#C# 61 ospemifene 61 lintuzumab 61 posaconazole 61 Daclizumab 61 Cethromycin 61 Iluvien ® 61 maturation inhibitor 61 Hsp# Inhibitor 61 trabedersen 61 Phase 1b 61 febuxostat 61 phase Ib 61 immunotherapeutic vaccine 61 PRT# 61 Rasagiline 61 PEGylated anti 61 autologous cellular immunotherapy 61 aripiprazole Abilify 61 Orphan Drug designations 61 Clolar ® 61 topical gel formulation 61 Firazyr 60 Azilect ® 60 glufosfamide 60 iniparib 60 Bortezomib 60 anti TNF alpha 60 Esbriet ® 60 Lubiprostone 60 HQK 60 telbivudine 60 SNT MC# 60 Nexavar sorafenib 60 ACZ# 60 selective androgen receptor modulators 60 Golimumab 60 olanzapine Zyprexa 60 maraviroc 60 Cloretazine ® 60 mTOR mammalian target 60 hyaluronidase enzyme 60 Tekturna HCT 60 Noxafil 60 PROMACTA 60 Kuvan R 60 nitazoxanide 60 metformin sulfonylurea 60 Rivaroxaban 60 LUX Lung 60 bevacizumab Avastin 60 prucalopride 60 sunitinib 60 lapatinib 60 HuMax CD# 60 Investigational Compound 60 ruxolitinib 60 Synavive 60 Hycamtin 60 Alvesco R 60 targeted radiotherapeutic 60 Promacta 60 clinical trial 60 epothilones 60 imatinib mesylate 60 TREDAPTIVE 60 Sapacitabine 60 anti CD3 antibody 60 gefitinib Iressa 60 PRISTIQ 60 UPLYSO 60 Phase IIIb clinical 60 XmAb# 60 Onco TCS 60 NUVIGIL 60 BYETTA ® 60 Genz # 60 raltegravir 60 AKT inhibitor 60 Orazol 60 acyclovir Lauriad R 60 OXi# 60 ELACYT 60 placebo controlled Phase 60 AAG geldanamycin analog 60 APPRAISE 60 selective antagonist 60 Lixisenatide 60 sapropterin dihydrochloride 60 metaglidasen 60 anti leukemic 60 mu opioid receptor antagonist 60 perampanel 60 pioglitazone HCl 60 placebo controlled clinical 60 PI3K/Akt pathway inhibitor 60 glatiramer acetate 60 Raptiva ® 60 BiTE antibody 60 Naproxcinod 60 Blinatumomab 60 vorinostat 60 Aptivus ® 60 abiraterone acetate 60 Fx #A 60 Bevacizumab 60 ONGLYZA ™ 60 hormone refractory prostate cancer 60 mapatumumab 60 SAR# [002] 60 RhuDex ® 60 ADAGIO study 60 erlotinib Tarceva ® 60 cetuximab Erbitux 60 etanercept Enbrel 60 anti muscarinic 60 HSP# inhibitor 60 VEGF Trap 60 amrubicin 60 Ophena TM 60 Rifaximin 60 radiation sensitizer 60 Tredaptive 60 tamibarotene 60 heavily pretreated 60 bortezomib Velcade ® 60 Aplidin 60 varespladib 60 Proxinium TM 60 Amplimexon 60 aclidinium bromide 60 Pharmacokinetics PK 60 Adalimumab 60 DDP# 60 dirucotide 60 vismodegib 60 investigational hepatitis C 60 CR# vcMMAE 60 Talabostat 60 Saxagliptin 60 Factor VIIa 60 eprotirome 60 IgG1 monoclonal antibody 60 PDX pralatrexate 60 octreotide acetate 60 intravenous IV formulation 60 MabCampath 60 LymphoStat B TM 60 OncoVEX GM CSF 60 TPI ASM8 60 NXL# 60 Onrigin 60 epothilone 60 dexpramipexole 60 MNTX 60 MBP# [001] 60 tolerability profile 60 Personalized Immunotherapy 60 Onconase 60 IAP inhibitor 60 Actemra tocilizumab 60 FTY# 60 Civacir 60 Zenvia Phase III 60 Degarelix 60 chronic lymphocytic leukemia CLL 60 nucleotide analogue 60 atrasentan 60 DermaVir Patch 60 JAK inhibitors 60 alkylating agent 60 Junovan 60 systemic RNAi therapeutic 60 ACTEMRA TM 60 Corlux 60 APD# 60 renin inhibitors 60 ZACTIMA 60 Revlimid lenalidomide 60 Apoptone 60 lupus nephritis 60 castration resistant prostate cancer 60 Phase III trials 60 Telavancin 60 vicriviroc 60 CIMZIA ™ 60 OMAPRO 60 Dacogen injection 60 MK #A [001] 60 clofarabine 60 VPRIV 60 pharmacokinetic profile 60 metformin HCl 60 cetuximab Erbitux ® 60 receptor antagonists 60 mGluR5 NAM 60 PARP inhibitor 60 histamine dihydrochloride 60 Elacytarabine 60 Phase Ib II 60 Omnitarg 60 Catena ® 60 Pertuzumab 60 Cyclooxygenase Inhibiting Nitric Oxide 60 Vicriviroc 60 nab paclitaxel 60 riociguat 60 Clonicel 60 Clofarabine 60 brivaracetam 60 2 methoxyestradiol 60 L BLP# 60 teriflunomide 60 nucleoside analogue 60 arbaclofen 60 Hedgehog pathway inhibitor 60 fingolimod 60 AQ4N 60 quetiapine fumarate 60 Pathway Inhibitor 60 APTIVUS r 60 Virulizin ® 60 isoform selective 60 HCD# [002] 60 GSK# [002] 60 MT# MEDI 60 Zoraxel 60 pramlintide 60 GLYX 60 luteinizing hormone releasing 60 interferon alfa 60 CEQ# 60 Ticagrelor 60 Pegasys ® 59 SPRYCEL ® 59 pivotal Phase 59 Lenalidomide 59 Inhalation Solution 59 CCX# 59 vilazodone 59 Fingolimod 59 phase 2a 59 novel immunomodulatory 59 Trimesta 59 interferon gamma 1b 59 Lu AA# 59 ADX# 59 docetaxel chemotherapy 59 DexaSite 59 nucleotide analog 59 Zarnestra 59 FOLOTYN 59 ruboxistaurin 59 docetaxel Taxotere 59 VQD 59 miconazole Lauriad ® 59 CRD5 59 Erbitux cetuximab 59 Omacetaxine mepesuccinate 59 dyskinesia PD LID 59 pradefovir 59 CANCIDAS 59 olaparib 59 omalizumab 59 XL# anticancer compounds 59 multikinase inhibitor 59 Pemetrexed 59 DPP4 59 Arranon 59 Pixuvri 59 ULORIC 59 Phase III 59 topical formulation 59 Aztreonam 59 afatinib 59 Zenvia ™ 59 ACOMPLIA R 59 Interferon alpha 59 nucleoside reverse transcriptase inhibitor 59 Afinitor 59 romiplostim 59 Anturol TM 59 NEBIDO 59 Tarvacin 59 leukemia AML 59 Aviptadil 59 dihydrochloride 59 opioid induced constipation 59 oral antiviral 59 metastatic renal cell carcinoma 59 Fibrillex TM 59 docetaxel Taxotere ® 59 RH1 59 MyVax R 59 bortezomib Velcade R 59 ProSavin 59 hypoxia activated prodrug 59 insulin sensitizing 59 Luteinizing Hormone Releasing Hormone 59 Sprycel dasatinib 59 REVLIMID lenalidomide 59 anti amnesic 59 ixabepilone 59 Avastin bevacizumab 59 Emselex 59 sitagliptin 59 atacicept 59 Initiate Phase 59 Azacitidine 59 aflibercept 59 Sebivo 59 gastrointestinal stromal tumors GIST 59 Horizant ™ 59 proteasome inhibitors 59 Teriflunomide 59 protease inhibitor 59 IGF 1R inhibitor 59 protease inhibitor PI 59 Ridaforolimus 59 LymphoStat B 59 APF# 59 inhibitor PPI 59 Phase IIa trials 59 HCV protease inhibitors 59 oral renin inhibitor 59 VAPRISOL 59 Benlysta belimumab 59 HoFH 59 Posiphen 59 confirmatory Phase III 59 Orathecin 59 TEMODAL 59 ponatinib 59 GALNS 59 Pivotal Phase III 59 PEGylated interferon beta 1a 59 SEROQUEL 59 JAK1 59 arzoxifene 59 omacetaxine mepesuccinate 59 Ilaris 59 oral proteasome inhibitor 59 IPLEX 59 cetuximab Erbitux R 59 Annamycin 59 PHX# 59 GlaxoSmithKline plc GSK 59 Teysuno 59 tafamidis 59 cediranib 59 Azixa 59 TRO# 59 sNDA 59 CD# monoclonal antibody 59 leukotriene receptor antagonist 59 JAK3 inhibitor 59 ALK inhibitor 59 ulimorelin 59 R roscovitine 59 rosuvastatin calcium 59 Vernakalant 59 CoFactor 59 Quinamed 59 chronic myeloid leukemia CML 59 ELIQUIS 59 dose escalation trial 59 Dalbavancin 59 mg dose 59 ISTODAX 59 AzaSite Plus 59 GLPG# 59 Certican 59 RE SURGE 59 OMNARIS HFA 59 APEX PD 59 mipomersen 59 dasatinib Sprycel 59 Tocilizumab 59 Pafuramidine 59 Desmoteplase 59 VELCADE 59 generation proteasome inhibitor 59 orBec 59 direct renin inhibitor 59 Topotecan 59 TMC# C# 59 Zorbtive TM 59 BENICAR 59 leading oral taxane 59 Arcalyst 59 TriRima 59 BCR ABL inhibitors 59 ALN TTR# 59 metastatic hormone refractory 59 receptor modulators 59 VIMOVO 59 mecamylamine 59 ALN TTR 59 celgosivir 59 Telintra 59 pegylated interferon alfa 2a 59 EMEND 59 pharmacokinetics PK 59 ranolazine 59 tenofovir Viread 59 BRIM2 59 iclaprim 59 beta 1a 59 Serdolect ® 59 Aplidin R 59 AZILECT 59 Dabigatran etexilate 59 Nuvion 59 class mGluR5 inhibitor 59 systemic juvenile idiopathic 59 HFA MDI 59 selective adenosine 59 BRILINTA 59 Leukine ® 59 Atiprimod 59 pan histone deacetylase 59 Ciclesonide 59 tanezumab 59 RELOVAIR ™ 59 Inhalation Aerosol 59 CDP# 59 huN# DM1 59 neuraminidase inhibitor 59 pregabalin Lyrica 59 dasatinib 59 Genasense ® oblimersen 59 pazopanib 59 pralatrexate 59 antiplatelet agent 59 SGLT2 inhibitor 59 beta2 agonist 59 Temsirolimus 59 BZL# 59 ALGRX 59 Fc fusion protein 59 indacaterol 59 milnacipran 59 Doxil 59 XL# [003] 59 Everolimus 59 R sorafenib tablets 59 Valdoxan 59 granted orphan 59 TYGACIL 59 Sitagliptin 59 Pralatrexate 59 Interferon beta 1a 59 Bronchitol 59 ABL inhibitor 59 Multaq R 59 boosted protease inhibitor 59 dose escalation study 59 histone deacetylase inhibitor 59 immunomodulating 59 antithrombotic 59 PEG PAL 59 sorafenib 59 small molecule chemotherapeutic 59 ATL# [002] 59 Hsp# inhibitors 59 anidulafungin 59 HGS ETR1 59 Leukine 59 Panzem R NCD 59 mRCC 59 Kuvan sapropterin dihydrochloride 59 intravenous formulation 59 Octreolin 59 favorable tolerability 59 Phase IIb Trial 59 cangrelor 59 Rituxan rituximab 59 refractory chronic lymphocytic 59 investigational immunotherapy 59 cancer neuroendocrine tumor 59 cutaneous T 59 cannabinor 59 Cetrorelix 59 palifosfamide 59 lymphoma CTCL 58 Certolizumab pegol 58 Tamibarotene 58 insulin sensitizers 58 regadenoson 58 SUTENT ® 58 ASONEP 58 investigational antiplatelet agent 58 quinolone 58 Vidofludimus 58 Exenatide 58 ofatumumab HuMax CD# 58 Valtropin 58 antibody MAb 58 reuptake inhibitor 58 mixed dyslipidemia 58 VA# [002] 58 systemic lupus erythematosus SLE 58 Trexima 58 BAL# [002] 58 antisense inhibitor 58 LEXIVA 58 S/GSK# 58 diabetic macular edema DME 58 Zelrix 58 esomeprazole Nexium 58 polymerase inhibitors 58 dimebon 58 tapentadol 58 chronic angina 58 PLK1 SNALP 58 cariprazine 58 agonist LABA 58 ocular formulation 58 anticonvulsant 58 Tarvacin TM 58 ritonavir boosted 58 Zoloft sertraline 58 Mirapexin 58 Jevtana 58 Reverset 58 standard chemotherapy regimen 58 pitavastatin 58 ACTEMRA 58 rheumatoid arthritis psoriatic arthritis 58 trastuzumab emtansine T DM1 58 Roche Pegasys 58 PA# [002] 58 IMC A#